quadazocine has been researched along with enkephalin-leu, ala(2)-arg(6)- in 1 studies
Studies (quadazocine) | Trials (quadazocine) | Recent Studies (post-2010) (quadazocine) | Studies (enkephalin-leu, ala(2)-arg(6)-) | Trials (enkephalin-leu, ala(2)-arg(6)-) | Recent Studies (post-2010) (enkephalin-leu, ala(2)-arg(6)-) |
---|---|---|---|---|---|
81 | 0 | 0 | 332 | 22 | 11 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kolar, F; Krylatov, AV; Lishmanov, YB; Maslov, LN; Naryzhnaya, NV; Ovchinnikov, MV; Stakheev, DL | 1 |
1 other study(ies) available for quadazocine and enkephalin-leu, ala(2)-arg(6)-
Article | Year |
---|---|
Myocardial resistance to ischemic and reperfusion injuries under conditions of chronic administration of opioid receptor agonists and antagonists.
Topics: Animals; Azocines; Enkephalin, Leucine-2-Alanine; Heart; Male; Myocardial Reperfusion Injury; Naltrexone; Narcotic Antagonists; Piperazines; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2008 |